A carregar...
PBPK Models for CYP3A4 and P‐gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin
According to current US Food and Drug Administration (FDA) and European Medicines Agency (EMA) guidance documents, physiologically based pharmacokinetic (PBPK) modeling is a powerful tool to explore and quantitatively predict drug‐drug interactions (DDIs) and may offer an alternative to dedicated cl...
Na minha lista:
| Publicado no: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6202474/ https://ncbi.nlm.nih.gov/pubmed/30091221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12343 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|